Clinical trial
Hyperphenylalaninemia in Cerebral Malaria
NCT00338520 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperphenylalaninemia in Cerebral Malaria
- Lead sponsor
- University of Utah
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- January 31, 2012
- Enrollment
- 285 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
plasmodium falciparum malaria